Dual evidence reveals the therapeutic efficacy of exosome-delivered miR-124-3p in spinal cord injury via a novel CTDSP1/WNT/β-catenin mechanism
- 5 June 2026
- journal article
- research article
- Published by Springer Nature in Spinal Cord
- p. 1-8
Abstract
Study Design Integrated preclinical systematic review and meta-analysis with basic experimental research. Objectives To evaluate the therapeutic efficacy of miR-124-3p in spinal cord injury (SCI) repair and elucidate its mechanism involving the CTDSP1/WNT/β‑catenin axis. Setting University-based laboratory in Lanzhou, China. Methods A meta‑analysis of five animal studies assessed the effects of miR‑124‑3p. In vitro, a lipopolysaccharide‑injured PC12 cell model was treated with exosomes derived from miR‑124‑3p‑overexpressing human umbilical cord mesenchymal stem cells. Mechanistic validation included dual‑luciferase reporter assay, qPCR, Western blot, and pathway inhibition/rescue experiments. Results The meta‑analysis showed that miR‑124‑3p significantly improved motor function, reduced glial scar marker GFAP and pro‑inflammatory cytokines, and increased neuronal/axonal markers (Map2, NF200, NeuN). Mechanistically, miR‑124‑3p directly targeted the 3′‑UTR of CTDSP1. Exosome‑delivered miR‑124‑3p downregulated CTDSP1, activated WNT/β‑catenin signaling, suppressed GFAP/CSPG, and promoted β‑tubulin III, NeuN, and NF200 expression. These effects were reversed by the WNT inhibitor MSAB and mimicked by a CTDSP1 inhibitor. Conclusions miR‑124‑3p promotes SCI repair primarily by targeting CTDSP1 to activate the WNT/β‑catenin pathway, thereby inhibiting glial scarring and enhancing neuronal survival/regeneration. This mechanism supports the therapeutic potential of combined exosome and miRNA strategies. The alternative text for this image may have been generated using AI.Keywords
This publication has 30 references indexed in Scilit:
- Nuclear MicroRNA-124-3p Promotes Neurite Outgrowth After Spinal Cord Injury by Enhancing Cttn TranscriptionMolecular Neurobiology, 2025
- Global, regional, and national burden of spinal cord injury from 1990 to 2021 and projections for 2050: A systematic analysis for the Global Burden of Disease 2021 studyAgeing Research Reviews, 2024
- Targeted Repair of Spinal Cord Injury Based on miRNA‐124‐3p–Loaded Mesoporous Silica Camouflaged by Stem Cell Membrane Modified with Rabies Virus GlycoproteinAdvanced Science, 2024
- Unravelling the Road to Recovery: Mechanisms of Wnt Signalling in Spinal Cord InjuryMolecular Neurobiology, 2024
- lncRNA XIST inhibition promotes M2 polarization of microglial and aggravates the spinal cord injury via regulating miR-124–3p / IRF1 axisHeliyon, 2023
- A miR-124-mediated post-transcriptional mechanism controlling the cell fate switch of astrocytes to induced neuronsStem Cell Reports, 2023
- Purpurogallin Reverses Neuronal Apoptosis and Enhances “M2” Polarization of Microglia Under Ischemia via Mediating the miR-124-3p/TRAF6/NF-κB AxisNeurochemical Research, 2022
- Human Umbilical Cord Mesenchymal Stem Cells Derived Exosomes Promote Neurological Function Recovery in a Rat Spinal Cord Injury ModelNeurochemical Research, 2022
- RETRACTED: An update on the role of miR-124 in the pathogenesis of human disordersBiomedicine & Pharmacotherapy, 2021
- Chitosan polyplex mediated delivery of miRNA-124 reduces activation of microglial cells in vitro and in rat models of spinal cord injuryNanomedicine: Nanotechnology, Biology and Medicine, 2016